Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Perez-Belmonte, LM; Torres-Pena, JD; Lopez-Carmona, MD; Ayala-Gutierrez, MM; Fuentes-Jimenez, F; Huerta, LJ; Munoz, JA; Rubio-Rivas, M; Madrazo, M; Garcia, MG; Montes, BV; Sola, JF; Ena, J; Ferrer, RG; Perez, CM; Ripper, CJ; Lecumberri, JJN; Acedo, IE; Canteli, SP; Cosio, SF; Martinez, FA; Rodriguez, BC; Perez-Martinez, P; Ramos-Rincon, JM; Gomez-Huelgas, R – 2020